15584345

Source:http://linkedlifedata.com/resource/pubmed/id/15584345

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0392747, umls-concept:C0684249, umls-concept:C2699893
pubmed:issue	9
pubmed:dateCreated	2004-12-8
pubmed:language	jpn
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9423321
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vascular Endothelial..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Synthetic, http://linkedlifedata.com/resource/pubmed/chemical/gefitinib
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0016-254X
pubmed:author	pubmed-author:NakanishiYoichiY
pubmed:issnType	Print
pubmed:volume	95
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	205-9
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:15584345-Antineoplastic Agents, pubmed-meshheading:15584345-Cell Cycle, pubmed-meshheading:15584345-Gene Therapy, pubmed-meshheading:15584345-Genes, erbB-1, pubmed-meshheading:15584345-Lung Neoplasms, pubmed-meshheading:15584345-Neovascularization, Pathologic, pubmed-meshheading:15584345-Quinazolines, pubmed-meshheading:15584345-Receptors, Vascular Endothelial Growth Factor, pubmed-meshheading:15584345-Tumor Suppressor Protein p53, pubmed-meshheading:15584345-Vaccines, Synthetic
pubmed:year	2004
pubmed:articleTitle	[Does molecular targeted therapy change the treatment for lung cancer?].
pubmed:affiliation	Department of Clinical Medicine, Internal Medicine, Division of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University.
pubmed:publicationType	Journal Article, Review